ID   PLPL2_RAT               Reviewed;         478 AA.
AC   P0C548;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2007, sequence version 1.
DT   24-JUL-2024, entry version 113.
DE   RecName: Full=Patatin-like phospholipase domain-containing protein 2 {ECO:0000305};
DE            EC=3.1.1.3 {ECO:0000250|UniProtKB:Q96AD5};
DE   AltName: Full=Adipose triglyceride lipase;
DE   AltName: Full=Calcium-independent phospholipase A2-zeta;
DE            Short=iPLA2-zeta;
DE            EC=3.1.1.4 {ECO:0000250|UniProtKB:Q96AD5};
GN   Name=Pnpla2 {ECO:0000312|RGD:1309044}; Synonyms=Atgl;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   INDUCTION.
RX   PubMed=16906479; DOI=10.1007/s00125-006-0336-y;
RA   Festuccia W.T., Laplante M., Berthiaume M., Gelinas Y., Deshaies Y.;
RT   "PPARgamma agonism increases rat adipose tissue lipolysis, expression of
RT   glyceride lipases, and the response of lipolysis to hormonal control.";
RL   Diabetologia 49:2427-2436(2006).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398 AND SER-422, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   INTERACTION WITH PLIN5.
RX   PubMed=23408028; DOI=10.1152/ajpregu.00418.2012;
RA   MacPherson R.E., Ramos S.V., Vandenboom R., Roy B.D., Peters S.J.;
RT   "Skeletal muscle PLIN proteins, ATGL and CGI-58, interactions at rest and
RT   following stimulated contraction.";
RL   Am. J. Physiol. 304:R644-R650(2013).
RN   [5]
RP   INTERACTION WITH PLIN5.
RX   PubMed=24303154; DOI=10.1002/phy2.84;
RA   Macpherson R.E., Vandenboom R., Roy B.D., Peters S.J.;
RT   "Skeletal muscle PLIN3 and PLIN5 are serine phosphorylated at rest and
RT   following lipolysis during adrenergic or contractile stimulation.";
RL   Physiol. Rep. 1:E00084-E00084(2013).
CC   -!- FUNCTION: Catalyzes the initial step in triglyceride hydrolysis in
CC       adipocyte and non-adipocyte lipid droplets (By similarity). Exhibits a
CC       strong preference for the hydrolysis of long-chain fatty acid esters at
CC       the sn-2 position of the glycerol backbone and acts coordinately with
CC       LIPE/HLS and DGAT2 within the lipolytic cascade (By similarity). Also
CC       possesses acylglycerol transacylase and phospholipase A2 activities (By
CC       similarity). Transfers fatty acid from triglyceride to retinol,
CC       hydrolyzes retinylesters, and generates 1,3-diacylglycerol from
CC       triglycerides (By similarity). Regulates adiposome size and may be
CC       involved in the degradation of adiposomes (By similarity). Catalyzes
CC       the formation of an ester bond between hydroxy fatty acids and fatty
CC       acids derived from triglycerides or diglycerides to generate fatty acid
CC       esters of hydroxy fatty acids (FAHFAs) in adipocytes (By similarity).
CC       Acts antagonistically with LDAH in regulation of cellular lipid stores
CC       (By similarity). Inhibits LDAH-stimulated lipid droplet fusion (By
CC       similarity). May play an important role in energy homeostasis (By
CC       similarity). May play a role in the response of the organism to
CC       starvation, enhancing hydrolysis of triglycerides and providing free
CC       fatty acids to other tissues to be oxidized in situations of energy
CC       depletion (By similarity). {ECO:0000250|UniProtKB:Q8BJ56,
CC       ECO:0000250|UniProtKB:Q96AD5}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a diacylglycerol + a fatty acid +
CC         H(+); Xref=Rhea:RHEA:12044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:28868; EC=3.1.1.3;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12045;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a 1,2-diacylglycerol + a fatty acid
CC         + H(+); Xref=Rhea:RHEA:35667, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:28868, ChEBI:CHEBI:49172;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35668;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a 1,3-diacylglycerol + a fatty acid
CC         + H(+); Xref=Rhea:RHEA:38495, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:28868, ChEBI:CHEBI:47777;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38496;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacyl-sn-glycerol + H2O = a 1,3-diacyl-sn-glycerol + a
CC         fatty acid + H(+); Xref=Rhea:RHEA:43732, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28868, ChEBI:CHEBI:64615,
CC         ChEBI:CHEBI:77272; Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43733;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacyl-sn-glycerol + H2O = a 2,3-diacyl-sn-glycerol + a
CC         fatty acid + H(+); Xref=Rhea:RHEA:38499, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28868, ChEBI:CHEBI:64615,
CC         ChEBI:CHEBI:75524; Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38500;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,3-diacylglycerol + a 1-acylglycerol = a triacylglycerol +
CC         glycerol; Xref=Rhea:RHEA:44440, ChEBI:CHEBI:17754, ChEBI:CHEBI:17855,
CC         ChEBI:CHEBI:35759, ChEBI:CHEBI:47777;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44441;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacylglycerol + a 1-acylglycerol = a triacylglycerol +
CC         glycerol; Xref=Rhea:RHEA:44436, ChEBI:CHEBI:17754, ChEBI:CHEBI:17855,
CC         ChEBI:CHEBI:35759, ChEBI:CHEBI:49172;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44437;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 a 1-acylglycerol = a 1,2-diacylglycerol + glycerol;
CC         Xref=Rhea:RHEA:44432, ChEBI:CHEBI:17754, ChEBI:CHEBI:35759,
CC         ChEBI:CHEBI:49172; Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44433;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + all-trans-retinol = a diacylglycerol + an
CC         all-trans-retinyl ester; Xref=Rhea:RHEA:44676, ChEBI:CHEBI:17336,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:63410;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44677;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoate + 1,2-di-(9Z-octadecenoyl)-glycerol + H(+)
CC         = 1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O; Xref=Rhea:RHEA:38379,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:52323, ChEBI:CHEBI:53753;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38381;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-
CC         octadecenoate + 1,3-di-(9Z-octadecenoyl)-glycerol + H(+);
CC         Xref=Rhea:RHEA:38387, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:53753, ChEBI:CHEBI:75735;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38388;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,3-di-(9Z-octadecenoyl)-glycerol + 1-(9Z-octadecenoyl)-
CC         glycerol = 1,2,3-tri-(9Z-octadecenoyl)-glycerol + glycerol;
CC         Xref=Rhea:RHEA:38331, ChEBI:CHEBI:17754, ChEBI:CHEBI:53753,
CC         ChEBI:CHEBI:75342, ChEBI:CHEBI:75735;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38332;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-glycerol + 1-(9Z-octadecenoyl)-
CC         glycerol = 1,2,3-tri-(9Z-octadecenoyl)-glycerol + glycerol;
CC         Xref=Rhea:RHEA:38327, ChEBI:CHEBI:17754, ChEBI:CHEBI:52323,
CC         ChEBI:CHEBI:53753, ChEBI:CHEBI:75342;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38328;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 1-(9Z-octadecenoyl)-glycerol = 1,2-di-(9Z-octadecenoyl)-
CC         glycerol + glycerol; Xref=Rhea:RHEA:38323, ChEBI:CHEBI:17754,
CC         ChEBI:CHEBI:52323, ChEBI:CHEBI:75342;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38324;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z-octadecenoyl)-glycerol + all-trans-retinol =
CC         all-trans-retinyl 9Z-octadecenoate + di-(9Z)-octadecenoylglycerol;
CC         Xref=Rhea:RHEA:39987, ChEBI:CHEBI:17336, ChEBI:CHEBI:53753,
CC         ChEBI:CHEBI:70760, ChEBI:CHEBI:75945;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39988;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z)-hexadecenoylglycerol + H2O = (9Z)-hexadecenoate
CC         + 1,3-di-(9Z)-hexadecenoylglycerol + H(+); Xref=Rhea:RHEA:38395,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32372,
CC         ChEBI:CHEBI:75841, ChEBI:CHEBI:75849;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38396;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z,12Z)-octadecadienoylglycerol + H2O = (9Z,12Z)-
CC         octadecadienoate + 1,3-di-(9Z,12Z)-octadecadienoylglycerol + H(+);
CC         Xref=Rhea:RHEA:38403, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:75844, ChEBI:CHEBI:75850;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38404;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z,12Z,15Z)-octadecatrienoylglycerol + H2O =
CC         (9Z,12Z,15Z)-octadecatrienoate + 1,3-di-(9Z,12Z,15Z)-
CC         octadecatrienoylglycerol + H(+); Xref=Rhea:RHEA:38411,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32387,
CC         ChEBI:CHEBI:75845, ChEBI:CHEBI:75852;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38412;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,3-di-(9Z)-octadecenoyl-2-hexadecanoylglycerol + H2O = 1,3-
CC         di-(9Z-octadecenoyl)-glycerol + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:38419, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:75735, ChEBI:CHEBI:75846;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38420;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z)-octadecenoyl-3-hexadecanoyl-sn-glycerol + H2O =
CC         (9Z)-octadecenoate + 1-(9Z)-octadecenoyl-3-hexadecanoyl-sn-glycerol +
CC         H(+); Xref=Rhea:RHEA:38423, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:75583, ChEBI:CHEBI:75867;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38424;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2,3-di-(9Z)-octadecenoyl-sn-glycerol + H2O =
CC         (9Z)-octadecenoate + 1-hexadecanoyl-3-(9Z)-octadecenoyl-sn-glycerol +
CC         H(+); Xref=Rhea:RHEA:38647, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:75847, ChEBI:CHEBI:75868;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38648;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-
CC         octadecenoate + 2,3-di-(9Z)-octadecenoyl-sn-glycerol + H(+);
CC         Xref=Rhea:RHEA:38391, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:53753, ChEBI:CHEBI:75824;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38392;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z)-hexadecenoylglycerol + H2O = (9Z)-hexadecenoate
CC         + 2,3-di-(9Z)-hexadecenoyl-sn-glycerol + H(+); Xref=Rhea:RHEA:38399,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32372,
CC         ChEBI:CHEBI:75841, ChEBI:CHEBI:75853;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38400;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z,12Z)-octadecadienoylglycerol + H2O = (9Z,12Z)-
CC         octadecadienoate + 2,3-di-(9Z,12Z)-octadecadienoyl-sn-glycerol +
CC         H(+); Xref=Rhea:RHEA:38407, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:75844, ChEBI:CHEBI:75854;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38408;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z,12Z,15Z)-octadecatrienoylglycerol + H2O =
CC         (9Z,12Z,15Z)-octadecatrienoate + 2,3-di-(9Z,12Z,15Z)-
CC         octadecatrienoyl-sn-glycerol + H(+); Xref=Rhea:RHEA:38415,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32387,
CC         ChEBI:CHEBI:75845, ChEBI:CHEBI:75855;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38416;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,3-di-(9Z)-octadecenoyl-2-hexadecanoylglycerol + H2O = (9Z)-
CC         octadecenoate + 2-hexadecanoyl-3-(9Z)-octadecenoyl-sn-glycerol +
CC         H(+); Xref=Rhea:RHEA:38431, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:75846, ChEBI:CHEBI:75870;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38432;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2,3-di-(9Z)-octadecenoyl-sn-glycerol + H2O =
CC         2,3-di-(9Z)-octadecenoyl-sn-glycerol + H(+) + hexadecanoate;
CC         Xref=Rhea:RHEA:38427, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:75824, ChEBI:CHEBI:75847;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38428;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z)-octadecenoyl-3-hexadecanoyl-sn-glycerol + H2O =
CC         (9Z)-octadecenoate + 2-(9Z-octadecenoyl)-3-hexadecanoyl-sn-glycerol +
CC         H(+); Xref=Rhea:RHEA:38643, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:75546, ChEBI:CHEBI:75583;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38644;
CC         Evidence={ECO:0000250|UniProtKB:Q8BJ56};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=3.1.1.4;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15802;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z-octadecenoyl)-glycerol + 9-hydroxy-octadecanoate
CC         = 2,3-di-(9Z)-octadecenoyl-sn-glycerol + 9-(9Z-octadecenoyloxy)-
CC         octadecanoate; Xref=Rhea:RHEA:75011, ChEBI:CHEBI:53753,
CC         ChEBI:CHEBI:75824, ChEBI:CHEBI:136282, ChEBI:CHEBI:136286;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2,3-di-(9Z)-octadecenoyl-sn-glycerol + 9-
CC         hydroxy-octadecanoate = 2,3-di-(9Z)-octadecenoyl-sn-glycerol + 9-
CC         hexadecanoyloxy-octadecanoate; Xref=Rhea:RHEA:75015,
CC         ChEBI:CHEBI:75824, ChEBI:CHEBI:75847, ChEBI:CHEBI:83670,
CC         ChEBI:CHEBI:136286; Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(10Z)-heptadecenoylglycerol + 9-hydroxy-
CC         octadecanoate = 2,3-di-(10Z-heptadecenoyl)-sn-glycerol + 9-(10Z-
CC         heptadecenoyloxy)-octadecanoate; Xref=Rhea:RHEA:75019,
CC         ChEBI:CHEBI:136286, ChEBI:CHEBI:194143, ChEBI:CHEBI:194145,
CC         ChEBI:CHEBI:228204; Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z,12Z)-octadecadienoylglycerol + 9-hydroxy-
CC         octadecanoate = 2,3-di-(9Z,12Z)-octadecadienoyl-sn-glycerol + 9-
CC         (9Z,12Z-octadecadienoyloxy)-octadecanoate; Xref=Rhea:RHEA:75023,
CC         ChEBI:CHEBI:75844, ChEBI:CHEBI:75854, ChEBI:CHEBI:136286,
CC         ChEBI:CHEBI:194142; Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z)-hexadecenoylglycerol + 9-hydroxy-octadecanoate
CC         = 2,3-di-(9Z)-hexadecenoyl-sn-glycerol + 9-(9Z-hexadecenoyloxy)-
CC         octadecanoate; Xref=Rhea:RHEA:75027, ChEBI:CHEBI:75841,
CC         ChEBI:CHEBI:75853, ChEBI:CHEBI:136286, ChEBI:CHEBI:136309;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + 9-hydroxy-octadecanoate
CC         = 2-(9Z-octadecenoyl)-glycerol + 9-(9Z-octadecenoyloxy)-
CC         octadecanoate; Xref=Rhea:RHEA:75031, ChEBI:CHEBI:52333,
CC         ChEBI:CHEBI:73990, ChEBI:CHEBI:136282, ChEBI:CHEBI:136286;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2,3-di-(9Z)-octadecenoyl-sn-glycerol + 9-
CC         hydroxy-octadecanoate = 1-hexadecanoyl-3-(9Z)-octadecenoyl-sn-
CC         glycerol + 9-(9Z-octadecenoyloxy)-octadecanoate;
CC         Xref=Rhea:RHEA:75035, ChEBI:CHEBI:75847, ChEBI:CHEBI:75868,
CC         ChEBI:CHEBI:136282, ChEBI:CHEBI:136286;
CC         Evidence={ECO:0000250|UniProtKB:Q96AD5};
CC   -!- PATHWAY: Glycerolipid metabolism; triacylglycerol degradation.
CC   -!- SUBUNIT: Interacts with ABHD5; this association stimulates PNPLA2
CC       triglyceride hydrolase activity (By similarity). Interacts with
CC       SERPINF1; this interaction stimulates the phospholipase A2 activity of
CC       PNPLA2 (By similarity). Despite a colocalization in lipid droplets, it
CC       probably does not interact with PLIN (By similarity). Interacts with
CC       PLIN5; prevents interaction with ABHD5 (PubMed:23408028,
CC       PubMed:24303154). Interacts with FAF2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BJ56, ECO:0000250|UniProtKB:Q96AD5,
CC       ECO:0000269|PubMed:23408028, ECO:0000269|PubMed:24303154}.
CC   -!- SUBCELLULAR LOCATION: Lipid droplet {ECO:0000250|UniProtKB:Q96AD5}.
CC       Cell membrane {ECO:0000250|UniProtKB:Q96AD5}; Multi-pass membrane
CC       protein {ECO:0000255}. Cytoplasm {ECO:0000250|UniProtKB:Q8BJ56}.
CC   -!- INDUCTION: Increased by rosiglitazone in subcutaneous and visceral
CC       white adipose tissue. {ECO:0000269|PubMed:16906479}.
CC   -!- PTM: Phosphorylation at Ser-398 by PKA is increased during fasting and
CC       moderate intensity exercise, and moderately increases lipolytic
CC       activity. {ECO:0000250|UniProtKB:Q8BJ56}.
CC   -!- PTM: Ubiquitinated by PEX2 in response to reactive oxygen species
CC       (ROS), leading to its degradation (By similarity). Ubiquitination is
CC       stimulated by LDAH (By similarity). {ECO:0000250|UniProtKB:Q96AD5}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC109542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001101979.2; NM_001108509.2.
DR   RefSeq; XP_003749062.1; XM_003749014.3.
DR   RefSeq; XP_017459687.1; XM_017604198.1.
DR   AlphaFoldDB; P0C548; -.
DR   SMR; P0C548; -.
DR   BioGRID; 262869; 1.
DR   STRING; 10116.ENSRNOP00000025319; -.
DR   GlyCosmos; P0C548; 1 site, No reported glycans.
DR   GlyGen; P0C548; 1 site.
DR   iPTMnet; P0C548; -.
DR   PhosphoSitePlus; P0C548; -.
DR   PaxDb; 10116-ENSRNOP00000025319; -.
DR   Ensembl; ENSRNOT00000025319.7; ENSRNOP00000025319.5; ENSRNOG00000069673.1.
DR   GeneID; 361676; -.
DR   KEGG; rno:361676; -.
DR   AGR; RGD:1309044; -.
DR   CTD; 57104; -.
DR   RGD; 1309044; Pnpla2.
DR   eggNOG; KOG3773; Eukaryota.
DR   GeneTree; ENSGT00940000160155; -.
DR   HOGENOM; CLU_018371_0_1_1; -.
DR   InParanoid; P0C548; -.
DR   OMA; TKWEEYQ; -.
DR   OrthoDB; 5395310at2759; -.
DR   PhylomeDB; P0C548; -.
DR   TreeFam; TF314272; -.
DR   Reactome; R-RNO-1482883; Acyl chain remodeling of DAG and TAG.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   UniPathway; UPA00256; -.
DR   PRO; PR:P0C548; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000018736; Expressed in heart and 18 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005811; C:lipid droplet; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0016411; F:acylglycerol O-acyltransferase activity; ISO:RGD.
DR   GO; GO:0051265; F:diolein transacylation activity; ISS:UniProtKB.
DR   GO; GO:0051264; F:mono-olein transacylation activity; ISS:UniProtKB.
DR   GO; GO:0004623; F:phospholipase A2 activity; ISS:UniProtKB.
DR   GO; GO:0050253; F:retinyl-palmitate esterase activity; ISS:UniProtKB.
DR   GO; GO:0004806; F:triglyceride lipase activity; ISS:UniProtKB.
DR   GO; GO:0044242; P:cellular lipid catabolic process; ISO:RGD.
DR   GO; GO:0006651; P:diacylglycerol biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0035356; P:intracellular triglyceride homeostasis; ISS:UniProtKB.
DR   GO; GO:1905691; P:lipid droplet disassembly; ISO:RGD.
DR   GO; GO:0160077; P:lipid droplet fusion; ISS:UniProtKB.
DR   GO; GO:0034389; P:lipid droplet organization; ISO:RGD.
DR   GO; GO:0055088; P:lipid homeostasis; IBA:GO_Central.
DR   GO; GO:0019915; P:lipid storage; ISO:RGD.
DR   GO; GO:0010891; P:negative regulation of sequestering of triglyceride; ISS:UniProtKB.
DR   GO; GO:0010898; P:positive regulation of triglyceride catabolic process; ISS:UniProtKB.
DR   GO; GO:0019433; P:triglyceride catabolic process; ISS:UniProtKB.
DR   CDD; cd07220; Pat_PNPLA2; 1.
DR   Gene3D; 3.40.1090.10; Cytosolic phospholipase A2 catalytic domain; 1.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR033562; PLPL.
DR   InterPro; IPR033903; PNPLA2.
DR   InterPro; IPR002641; PNPLA_dom.
DR   PANTHER; PTHR12406; CALCIUM-INDEPENDENT PHOSPHOLIPASE A2 IPLA2 -RELATED; 1.
DR   PANTHER; PTHR12406:SF29; PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING PROTEIN 2; 1.
DR   Pfam; PF01734; Patatin; 1.
DR   SUPFAM; SSF52151; FabD/lysophospholipase-like; 1.
DR   PROSITE; PS51635; PNPLA; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cytoplasm; Glycoprotein; Hydrolase; Isopeptide bond;
KW   Lipid degradation; Lipid droplet; Lipid metabolism; Membrane;
KW   Phosphoprotein; Reference proteome; Signal-anchor; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..478
FT                   /note="Patatin-like phospholipase domain-containing protein
FT                   2"
FT                   /id="PRO_0000292529"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q96AD5"
FT   TRANSMEM        9..29
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        30..42
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q96AD5"
FT   TRANSMEM        43..63
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        64..137
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q96AD5"
FT   TRANSMEM        138..158
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        159..323
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q96AD5"
FT   TRANSMEM        324..344
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        345..478
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q96AD5"
FT   DOMAIN          10..179
FT                   /note="PNPLA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   REGION          456..478
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           14..19
FT                   /note="GXGXXG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           45..49
FT                   /note="GXSXG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOTIF           166..168
FT                   /note="DGA/G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   ACT_SITE        47
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   ACT_SITE        166
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01161"
FT   MOD_RES         366
FT                   /note="Phosphoserine; in vitro"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BJ56"
FT   MOD_RES         388
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BJ56"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         422
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         460
FT                   /note="Phosphoserine; in vitro"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BJ56"
FT   CARBOHYD        39
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        92
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96AD5"
SQ   SEQUENCE   478 AA;  52567 MW;  E6B8294E47631410 CRC64;
     MFPRETKWNI SFAGCGFLGV YHIGVASCLR EHAPFLVANA THIYGASAGA LTATALVTGA
     CLGEAGANII EVSKEARKRF LGPLHPSFNL VKTIRGCLLK TLPADCHTRA SGRLGISLTR
     VSDGENVIIS HFSSKDELIQ ANVCSTFIPV YCGLIPPTLQ GVRYVDGGIS DNLPLYELKN
     TITVSPFSGE SDICPQDSST NIHELRITNT SIQFNLRNLY RLSKALFPPE PMVLREMCKQ
     GYRDGLRFLR RNGLLNQPNP LLALPPVVPQ EEDAEEAAVT EERTGGEDRI LEHLPARLNE
     ALLEACVEPK DLMTTLSNML PVRLATAMMV PYTLPLESAV SFTIRLLEWL PDVPEDIRWM
     KEQTGSICQY LVMRAKRKLG DHLPSRLSEQ VELRRAQSLP SVPLSCATYS EALPNWVRNN
     LSLGDALAKW EECQRQLLLG LFCTNVAFPP DALRMRAPAS PTATDPATPQ DPSGLPPC
//
